• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4603440)   Today's Articles (4495)   Subscriber (49369)
For: Oztop N, Demir S, Unal D, Beyaz S, Terzioglu K, Olgac M, Gelincik A. Predictive factors of recurrence after omalizumab cessation in the elderly with urticaria: A real-life study. Allergy Asthma Proc 2022;43:519-528. [PMID: 36335414 DOI: 10.2500/aap.2022.43.220068] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Number Cited by Other Article(s)
1
Structures and Anti-Allergic Activities of Natural Products from Marine Organisms. Mar Drugs 2023;21:md21030152. [PMID: 36976202 PMCID: PMC10056057 DOI: 10.3390/md21030152] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/26/2022] [Revised: 02/18/2023] [Accepted: 02/23/2023] [Indexed: 03/02/2023]  Open
2
Bellanti JA, Settipane RA. A confluence of advanced treatment options for atopic dermatitis, eosinophilic lung diseases and chronic urticaria brought about by the revolutionary discovery of biologics and Janus kinase inhibitors. Allergy Asthma Proc 2022;43:471-473. [PMID: 36335419 PMCID: PMC9645732 DOI: 10.2500/aap.2022.43.220081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA